N/A
N=10
Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)
Postpartum Hemorrhage
Bottom Line
View on ClinicalTrials.gov: NCT01497756 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcome: Primary: Usage — 10 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CAPP use (Device)
- Age
- Pediatric, Adult, Older Adult
- Sex
- Female
- Sponsor
- University of New Mexico
- Primary completion
- May 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Usage |
10 | — |
| SECONDARY Side Effects |
— | — |
Summary
A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.
Eligibility Criteria
Inclusion Criteria
- Any patient receiving CAPP during study period.
Exclusion Criteria
- None (CAPP is only clinically indicated for obstetric hemorrhage post delivery.
Data sourced from ClinicalTrials.gov (NCT01497756). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.